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Introduction
Cell proliferation requires gene expression to drive the cell cycle 
and to provide sufficient protein synthesis for cell growth. Several 
transcription factors are key mediators of gene expression dur-
ing the cell cycle, including E2F1, which regulates cell prolifera-
tion and apoptosis.1 E2F1 has been demonstrated to upregulate 
both transcription and formation of the 7-methylguanosine cap 
or methyl cap.2 The methyl cap is a structure added to the 5' end 
of RNA pol II transcripts that is essential for gene expression, 
mediating processes including transcript stabilization, splicing, 
nuclear export and translation initiation.3,4 Regulation of methyl 
cap abundance has been observed in mammalian cells and yeast 
under conditions which influence cell growth and proliferation,2,5 
and mRNA cap methylation has been demonstrated to be rate-
limiting for gene expression and cell proliferation.6-8
Methyl cap formation occurs early during transcription, and 
the enzymes which promote its formation, Capping enzyme (CE) 
and RNA guanine-7 methyltransferase (RNMT), are recruited 
to transcription initiation sites via an interaction with RNA pol 
II.3,4 Transcripts are synthesized with a triphosphate group on 
the 5' terminus, and Capping enzyme catalyzes removal of the 
terminal phosphate and addition of an inverted guanosine cap 
to create the structure GpppX (X is the first transcribed nucleo-
tide). RNA guanine-7 methyltransferase methylates the guano-
sine cap at the N-7 position to create the methyl cap, m7GpppX. 
RNA polymerase II is phosphorylated on the C-terminal domain 
(CTD) at the initiation of transcription, thus forming a docking 
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site for CE and RNMT. The RNA pol II CTD has been dem-
onstrated to be required for efficient methyl cap formation on 
transcripts produced from reporter constructs;3,4 however, to our 
knowledge, RNA pol II phosphorylation has not been demon-
strated to be required for methyl cap formation on endogenous 
transcripts.
Results and Discussion
In this study, we investigated regulation of methyl cap formation 
by E2F1 on its target transcript, the cyclin-dependent kinase, 
CDC2. E2F1 activity was regulated in fibroblasts by activation 
of E2F1-ER, a fusion protein of E2F1 and the estrogen recep-
tor (ER).9 E2F1-ER is retained in the cytoplasm until addition 
of the ER ligand, 4-hydroxytamoxifen, promotes its movement 
to the nucleus, where it binds E2F1 recognition motifs proximal 
to transcription initiation sites.9 E2F1-ER was activated for 3 h; 
RNA was extracted, and RTPCR was used to demonstrate that 
the expression level of its target transcript, CDC2, was upregu-
lated, whereas a control gene, GAPDH, was not (Fig. 1A). As 
had been observed previously, activation of E2F1 also resulted 
in an increase in the proportion of CDC2 transcripts with a 
methyl cap, as determined by anti-7-methylguanosine antibody 
immunoprecipitation followed by RTPCR (Fig. 1B). Methyl cap 
formation is dependent on recruitment of the methyl cap syn-
thetic enzymes CE and RNMT to phosphorylated RNA pol II. 
Activation of E2F1 resulted in increased RNA pol II Ser-5 phos-
phorylation (Fig. 1C).© 2012 Landes Bioscience.
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D, CDC2 transcripts were depleted by approximately 50%, and 
CDC2 transcript levels became unresponsive to E2F1 (Fig. 2B).
The effect of the transcriptional inhibitors on E2F1-
dependent methyl cap formation was determined by anti-
7-methylguanosine antibody immunoprecipitation followed by 
CDC2 RTPCR. DRB treatment prevented the E2F1-dependent 
increase in the proportion of CDC2 transcripts with a methyl 
cap (Fig. 2C). This is consistent with the finding that CE and 
RNMT are recruited to phosphorylated RNA pol II at transcrip-
tion initiation sites and validates the finding that RNA pol II 
phosphorylation is required for methyl cap formation on reporter 
construct transcripts. A surprising result was that Actinomycin 
D did not affect methyl cap formation on CDC2 transcripts. 
Since Actinomycin D and DRB inhibit transcription equiva-
lently, whereas only DRB inhibits cap methylation, methyl cap 
formation is not dependent on full engagement of the transcrip-
tion machinery.
Materials and Methods
Cell culture. Cells were maintained in DMEM supplemented 
with 10% fetal bovine serum, at 37°C/5% CO2. Rat fibroblasts 
were transduced with a retroviral expression vector directing 
expression of E2F1-ER.9
RNA analysis. RNA was extracted using Trizol reagent 
(Invitrogen) and further purified by phenol extraction. Oligo 
dT-cellulose (Ambion) purification was performed prior to 
anti-7-methylguanosine immunoprecipitation.2 RTPCR was 
performed using gene-specific primers, all of which produced 
sequence-verified products.
RNA pol II detection. Cells were lysed in hypotonic lysis buf-
fer and nuclear proteins extracted in Triton lysis buffer (10 mM 
Tris, pH 7.05, 50 mM NaCl, 30 mM Na4 pyrophosphate, 50 
mM NaF, 5 μM ZnCl2, 10% glycerol, 0.5% Triton X-100, 10 
μM Leupeptin, 1 μM Pepstatin and Aprotinin, supplemented 
with Phosphatase Inhibitor Cocktail I and II, Sigma). Twenty μg 
nuclear extract was resolved by SDS-PAGE and RNA pol II was 
detected by western blot (total RNA pol II SC-899, Santa Cruz 
Biotech, Ser-5 phosphorylated RNA pol II, H14 Convance).
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In order to determine the role of RNA pol II phosphoryla-
tion and transcription in the mechanism of methyl cap forma-
tion, cells were incubated with two inhibitors, Actinomycin D, 
a compound that forms a complex with DNA preventing 
movement of RNA polymerase, and DRB (Dichloro-1-β-D-
ribofuranosylbenzimidazole riboside), an adenosine analog 
which inhibits RNA pol II kinases and, therefore, RNA pol II 
phosphorylation. The rate of RNA pol II transcription was deter-
mined by measuring the rate of 3H-uridine incorporation into 
oligo-dT-purified RNA (predominantly mRNA). Incubating 
cells for 30 min with 175 nM Actinomycin D or 5 μM DRB 
inhibited RNA pol II-dependent transcription by approximately 
90% (Fig. 2A). Following treatment with DRB or Actinomycin 
Figure 1. e2F1 regulates RNA pol II phosphorylation and cap methyla-
tion. e2F1-eR expressed in rat fibroblasts was activated by addition of 
100 nM 4-hydroxytamoxifen (+) or vehicle control (-) for 3 h. (A) RNA 
was extracted and Rt-pCR performed with primers specific for CDC2 
and GApDH. (B) RNA was oligo-dt-purified (total transcripts, gray bars) 
and subsequently anti-m7G-purified (m7G transcripts, black bars) and 
Rt-pCR performed with primers specific for CDC2. (C) e2F1-eR was acti-
vated by incubation in 100 nM 4-hydroxytamoxifen (oHt) for the time 
course indicated. Western blotting was used to detect total RNA pol II 
and Ser-5 phosphorylated RNA pol II in nuclear extracts.© 2012 Landes Bioscience.
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Figure 2. e2F1-dependent cap methylation requires RNA pol II phosphorylation. (A) Rat fibro-
blasts were incubated with 175 nM Actinomycin D (ActD), 5 μM DRB or vehicle control (-), for 30 
min prior to addition of 10 μci/ml 3H uridine for 15 min. RNA was harvested, oligo-dt-purified and 
3H uridine incorporation determined. (B) Following treatment with Act D or DRB, e2F1-eR was 
activated by addition of 100 nM 4-hydroxytamoxifen for 3 h (oHt). RNA was extracted, oligo-dt-
purified and Rt-pCR performed with primers specific for CDC2. (C) As in (b), RNA was oligo-dt-pu-
rified (total transcripts, gray bars) and anti-m7G-purified (m7G transcripts, black bars) and Rt-pCR 
performed with primers specific for CDC2. Charts represent the average of three independent 
experiments and error bars indicate the standard deviation.